Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF-Endoret for Alveolar Ridge Preservation
NCT04945629Phase 3Completed
- Sponsor
- Fundación Eduardo Anitua
- Start
- Sep 2020
- Primary completion
- Jan 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised trial of PRGF-Endoret in Alveolar ridge resorption (2 arms), sponsored by Fundación Eduardo Anitua. Primary endpoint: Bone regeneration. Started Sep 2020; status: completed.
02
Drugs
PRGF-Endoret
03
Conditions
Alveolar ridge resorption
Beyond the preview
Go deeper on NCT04945629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04945629.